Table 1.
Patient characteristics.
| All patients (N = 235) | |
|---|---|
| Sex, male/female, n (%) | 176/59 (74.9/25.1) |
| Median age (years) | 72 |
| HBV infection, yes/no, n (%) | 50/185 (21.3/78.7) |
| HCV infection, yes/no, n (%) | 71/164 (30.2/69.8) |
| Number of tumors, median | 1 (1–6) |
| Solitary/multiple, n (%) | 178/57 (75.7/24.3) |
| Largest tumor size (cm), median | 3.6 |
| Serum AFP level (ng/mL), median | 8.9 (1–37780) |
| Child–Pugh grade, A/B, n (%) | 227/8 (96.6/3.4) |
| ALBI grade, I/II or III, n (%) | 231/4 (98.3/1.7) |
| FLIS 6/2–5, n (%) | 185/50 (78.7/21.3) |
| Microscopic portal vein invasion, +/-, n (%) | 43/192 (18.3/81.7) |
| Microscopic hepatic vein invasion, +/-, n (%) | 12/223 (5.1/94.9) |
| Microvascular invasion, +/-, n (%) | 55/180 (23.4/76.6) |
| Surgical procedure, minor resection/major resection, n (%) | 202/33 (86.0/14.0) |
| Anatomic resection/non-anatomic resection, n (%) | 174/61 (74.0/26.0) |
HBV Hepatitis B virus, HCV Hepatitis C virus, AFP alpha-fetoprotein, ALBI grade albumin–bilirubin grade, FLIS Functional liver imaging score.